Fully remote versus hybrid supervision of pulmonary telerehabilitation in COVID-19: a randomized clinical trial

被引:0
|
作者
Vian, Bruna S. [1 ,2 ]
Ratti, Ligia S. [1 ]
Resende, Mariangela R. [3 ]
Conterno, Lucieni de O. [3 ]
Pereira, Monica C. [2 ]
机构
[1] Univ Estadual Campinas, Univ Hosp, Physiotherapy & Occupat Therapy Serv, Campinas, Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Div Pneumol, Campinas, Brazil
[3] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Div Infectivol, Campinas, Brazil
基金
巴西圣保罗研究基金会;
关键词
Telerehabilitation; COVID-19; Walk test; Quality of life; 6-MINUTE WALK; STATEMENT; DISEASE; REHABILITATION; ADULTS; TESTS;
D O I
10.23736/S1973-9087.24.08634-9
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
BACKGROUND: The restrictions imposed by the COVID-19 pandemic have impeded the traditional rehabilitation process, prompting the widespread adoption of remote programs for the recovery of survivors. AIM: The aim of this study was to evaluate and compare the effectiveness of a pulmonary telerehabilitation program (PTRP) in the exclusively remote modality versus the hybrid modality (remote and face-to-face) in patients with persistent respiratory dysfunction following hospitalization for COVID-19 pneumonia, and to compare the functional capacity of patients who participated in a PTRP with those who did not. DESIGN: A randomised, interventional, prospective clinical trial was conducted. In parallel, an observational cohort study was conducted. SETTING: Outpatient rehabilitation clinic and home-based rehabilitation program. POPULATION: Thirty patients post-COVID-19 were randomised into two groups: G1 (fully remote supervision of PTRP) or G2 (hybrid supervision of PTRP). Thirty-seven post-COVID-19 patients were followed up without participating in PTRP (non-intervention group- NIG). METHODS: Patients with persistent respiratory dysfunction and reduced functional capacity, as measured by the Six Minute Walk Test (6MWT), after hospitalization for COVID-19 pneumonia, were considered eligible for a PTRP. To assess the efficacy of the PTRP, the primary outcome (I) was distance walked on the 6MWT (6MWD) and the secondary outcome (II) was quality of life as assessed by the SF-36 questionnaire. RESULTS: Both G1 and G2 demonstrated similar improvement in 6MWD, P<0.001 and quality of life (P<0.05). The IG showed higher 6MWD than the NIG (P<0.001). The increase in 6MWD for the IG was 140.5 m, while for the NIG it was 16.8 m (P=0.002). CONCLUSIONS: The PTRP was found to be a feasible and highly effective intervention for restoring functional capacity and improving quality of life, regardless of the type of supervision. Furthermore, this functional gain was maintained over the long term. In patients with pulmonary dysfunction, participation in the PTRP improved functional capacity compared with those who were simply advised to resume physical activity during recovery. CLINICAL REHABILITATION IMPACT: Telerehabilitation has been demonstrated to be a viable and efficacious alternative to traditional inperson programs in low-income contexts.
引用
收藏
页码:141 / 153
页数:13
相关论文
共 50 条
  • [41] Utilizing the sublingual form of squalene in COVID-19 patients: a randomized clinical trial
    Mahmoud Ebrahimi
    Nafiseh Farhadian
    Sara Saffar Soflaei
    Alireza Amiri
    Davoud Tanbakuchi
    Rozita Khatamian Oskooee
    Mohammad Karimi
    Scientific Reports, 14
  • [42] Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
    Darazam, Ilad Alavi
    Shokouhi, Shervin
    Mardani, Masoud
    Pourhoseingholi, Mohamad Amin
    Rabiei, Mohammad Mahdi
    Hatami, Firouze
    Shabani, Minoosh
    Moradi, Omid
    Gharehbagh, Farid Javandoust
    Irvani, Seyed Sina Naghibi
    Amirdosara, Mahdi
    Hajiesmaeili, Mohammadreza
    Rezaei, Omidvar
    Khoshkar, Ali
    Lotfollahi, Legha
    Gachkar, Latif
    Dehbsneh, Hadiseh Shabanpour
    Khalili, Negar
    Soleymaninia, Azam
    Kusha, Akram Hoseyni
    Shoushtari, Maryam Taleb
    Torabinavid, Parham
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [43] A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial
    Victoria, Lindsay W.
    Oberlin, Lauren E.
    Ilieva, Irena P.
    Jaywant, Abhishek
    Kanellopoulos, Dora
    Mercaldi, Catherine
    Stamatis, Caitlin A.
    Farlow, Deborah N.
    Kollins, Scott H.
    Tisor, Ochuwa
    Joshi, Sama
    Doreste-Mendez, Raura
    Perlis, Roy H.
    Gunning, Faith M.
    NEUROPSYCHOPHARMACOLOGY, 2024, 50 (02) : 472 - 479
  • [44] Role of ivermectin and colchicine in the treatment of COVID-19: a randomized controlled clinical trial
    Salama, Hemmat Abd El-Salam Ahmed
    Ahmed, Eman El-Sayed
    Amin, Ghada Essam El-Din
    Allam, Mohamed Farouk
    Hassan, Ahmed Nour El-Din
    El Shayeb, Mohamed Abd El Rahman Hassan
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (12): : S298 - S304
  • [45] Survival of the hospitalized patients with COVID-19 receiving atorvastatin: A randomized clinical trial
    Ghafoori, Majid
    Saadati, Hassan
    Taghavi, Mohammadreza
    Azimian, Amir
    Alesheikh, Peiman
    Mohajerzadeh, Mina Sadat
    Behnamfar, Morteza
    Pakzad, Marzieh
    Rameshrad, Maryam
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (07) : 3160 - 3168
  • [46] Efficacy of oral indomethacin in the treatment of COVID-19 infection; a randomized clinical trial
    Salmasi, Mehrzad
    Pourajam, Samaneh
    Ashrafi, Farzaneh
    Soltaninejad, Forogh
    Amra, Babak
    Ahmadikia, Zeinab
    Torki, Mehdi
    Darakhshandeh, Ali
    IMMUNOPATHOLOGIA PERSA, 2024, 10 (02):
  • [47] The Efficacy and Safety of Sitagliptin Administration in Patients with Covid-19: A Randomized Clinical Trial
    Toudeshki, Nahid Etemadi
    Ahmad, Zahra Ameri
    Dastan, Farzaneh
    Oveili, Elham
    Kiani, Arda
    Abedini, Atefeh
    Zare, Ahad
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2023, 7 (02): : 260 - 264
  • [48] Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomized Clinical Trial
    Shoumann, Waheed M.
    Hegazy, Abdelmonem Awad
    Nafae, Ramadan M.
    Ragab, Moustafa, I
    Samra, Saad R.
    Ibrahim, Dalia Anas
    AL-Mahrouky, Tarek H.
    Sileem, Ashraf E.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (02) : OC27 - OC32
  • [49] Methylene blue for COVID-19 ARDS: insights from a randomized Clinical Trial
    Sanei, Zahra Sadat
    Shahrahmani, Fatemeh
    Manesh, Behrooz Khaleghi
    Hamidi-alamdari, Daryoush
    Mehrad-Majd, Hassan
    Darban, Behzad Mavaji
    Mirdoosti, Seyedeh Motahareh
    Seddigh-Shamsi, Mohsen
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, 398 (02) : 1915 - 1924
  • [50] Safety and Efficacy of Incentive Spirometer in Covid-19 Pneumonia; a Randomized Clinical Trial
    Bargahi, Mohammad
    Alavi-Moghaddam, Mostafa
    Karimi, Mehdi
    Azizan, Zahra
    Jafarzadeh, Fateme
    Javaherian, Mohammad
    Soleimantabar, Hussein
    Mirbehbahani, Seyed Hamidreza
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2024, 12 (01)